Pidilizumab

DB15383InvestigationalProtein Based Therapies

Pidilizumab is under investigation in clinical trial NCT01952769 (Anti PD1 Antibody in Diffuse Intrinsic Pontine Glioma).

Mechanism: Pharmacologically active on Programmed cell death protein 1
Curator reviewed

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

420Drug interactionsStructured to mechanism, not free text

4Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Pidilizumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.